Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602145 · ClinicalTrials.gov registry record
Optimal Stent Selection for the Femoropopliteal Artery
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02602145 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 5 participants.
The verdict
NCT02602145 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Angioplasty and stenting for atherosclerotic occlusive disease in the arteries supplying the legs (Peripheral Arterial Disease, PAD) is the most common endovascular procedure outside of the heart, but carries the highest rate of reconstruction failure. The underlying reasons for these poor results are not completely clear, but the main arterial segment within the leg, the femoropopliteal artery, appears to be significantly different from other peripheral arteries because the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) that comprise the femoropopliteal artery (FPA) segment, undergo large deformations during flexion of the limb. We propose to build mathematical models of human FPAs repaired with several frequently used PAD stents. These mathematical models would be able to assess the mechanical stress in the stented SFA and PA associated with limb flexion and predict disease recurrence for arteries with different patient and lesion characteristics. Results of model predictions will be validated in patients with PAD stents who have received these stents as part of their standard of care.
Interventions
- OTHER follow-up CTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-09-02 |
| Est. Completion | 2021-04-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02602145
The ClinicalTrials.gov registry entry for NCT02602145 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which follow-up CTA is the first listed.
NCT02602145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02602145 about?
NCT02602145 is a clinical study titled "Optimal Stent Selection for the Femoropopliteal Artery". Angioplasty and stenting for atherosclerotic occlusive disease in the arteries supplying the legs (Peripheral Arterial Disease, PAD) is the most common endovascular procedure outside of the heart, but carries the highest rate of reconstruction failure. The underlying reasons for these poor results a...
What is the current status of trial NCT02602145?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2014-09-02. Estimated completion is 2021-04-16.
What interventions are being tested in trial NCT02602145?
The interventions under investigation include: follow-up CTA (OTHER).
Who is sponsoring clinical trial NCT02602145?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.